Feed excerpt — reported by STAT News
Incoming Democratic chairs of key committees have taken a step toward investigating MFN drug pricing agreements between drugmakers and the Trump administration.
MAP records observable characteristics of the original article (publisher, author, date, references, framing cues). MAP does not verify the article’s claims or score it. Read the full original story at STAT News →